XML 20 R9.htm IDEA: XBRL DOCUMENT
v3.25.2

BALANCE SHEET COMPONENTS | 6 Months Ended
--- | ---
Jun. 30, 2025
BALANCE SHEET COMPONENTS |
BALANCE SHEET COMPONENTS |
| 3. | BALANCE SHEET COMPONENTS
Inventories The Company had the following major classes of inventories: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | June 30, 2025 |  | December 31, 2024
​ | ​ | (amounts, in thousands)
Raw materials | ​ | $ | 491 | ​ | $ | 570
Work in process | ​ |  | 782 | ​ |  | 503
Finished goods | ​ |  | 2,437 | ​ |  | 1,660
Inventories | ​ | $ | 3,710 | ​ | $ | 2,733
​ Property and equipment, net The Company’s property and equipment consist of the following: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Depreciation/
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Amortization
​ |  | June 30, 2025 |  | December 31, 2024 |  | Period
​ | ​ | (amounts, in thousands) | ​ | ​
Furniture and fixtures | ​ | $ | 1,599 | ​ | $ | 1,454 |  | 7 years
Equipment and computers | ​ |  | 5,557 | ​ |  | 5,491 |  | 3 to 7 years
Leasehold improvements | ​ |  | 6,308 | ​ |  | 6,283 |  | Lesser of term of lease or estimated useful life
​ | ​ |  | 13,464 | ​ |  | 13,228 | ​ | ​
Less accumulated depreciation and amortization | ​ |  | 4,998 | ​ |  | 4,226 |  |
Property and equipment, net | ​ | $ | 8,466 | ​ | $ | 9,002 |  |
​ Depreciation expense for the six months ended June 30, 2025 and 2024 amounted to $0.6 million and $0.8 million, respectively. Other assets Other assets consist of the following: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | June 30, 2025 |  | December 31, 2024
​ | ​ | (amounts, in thousands)
Patent applications pending | ​ | $ | 1,722 | ​ | $ | 1,612
Patents issued | ​ |  | 3,391 | ​ |  | 3,391
Less accumulated amortization of patents issued | ​ |  | (1,374) | ​ |  | (1,255)
Patents, net | ​ |  | 3,739 | ​ |  | 3,748
Other | ​ |  | 53 | ​ |  | 23
Other assets | ​ | $ | 3,792 | ​ | $ | 3,771
​ Patent amortization expenses amounted to $0.1 million for the six months ended June 30, 2025 and 2024. Patent amortization expense for the next five years and thereafter is scheduled as follows: ​
​ | ​ | ​ | ​
​ | ​ | (amounts, in thousands)
Remainder of 2025 |  | $ | 97
2026 | ​ |  | 257
2027 | ​ |  | 251
2028 | ​ |  | 238
2029 | ​ |  | 238
Thereafter | ​ |  | 936
Scheduled amortization of patents issued | ​ | $ | 2,017
​ Accrued expenses and other current liabilities Accrued expenses and other current liabilities consist of the following: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | June 30, 2025 |  | December 31, 2024
​ | ​ | (amounts, in thousands)
Accrued salaries and commissions | ​ | $ | 3,397 | ​ | $ | 3,076
Clinical studies | ​ |  | 567 | ​ |  | 590
Deferred revenue | ​ |  | 361 | ​ |  | 419
Professional fees | ​ | ​ | 356 | ​ | ​ | 773
Royalties | ​ | ​ | 287 | ​ | ​ | 275
Goods received not invoiced | ​ | ​ | 20 | ​ | ​ | 87
Other | ​ |  | 965 | ​ |  | 812
Accrued expenses and other current liabilities | ​ | $ | 5,953 | ​ | $ | 6,032
​

X
- References No definition available. + Details
Name: | us-gaap_BalanceSheetRelatedDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/210/tableOfContent + Details
Name: | us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration